Duran Felipe 4

What Happened Duran Felipe, Chief Financial Officer of iBio, Inc. (IBIO), made an open-market purchase of 24,835 shares on March 19, 2026. The shares were acquired at prices in a narrow range ($2.01–$2.02) with a weighted average price of $2.0186, for a total reported outlay of approximately $50,132. This transaction is coded as a purchase (P), which is generally viewed as a direct acquisition of company stock.

Key Details

• Transaction date: 2026-03-19 (filed on Form 4: 2026-03-23; filing appears timely)
• Shares purchased: 24,835
• Price: range $2.01–$2.02; weighted average $2.0186 (rounded $2.02)
• Total value: ~$50,132
• Transaction type/code: Open-market purchase (P)
• Shares owned after transaction: Not specified in the provided Form 4 excerpt
• Footnote: Reporting person states purchases occurred in multiple trades within the $2.01–$2.02 range and will provide a per-trade breakdown upon request to the company, shareholders, or SEC staff

Context This was a straight purchase of common stock (not an option exercise, gift, or tax withholding). Purchases by executives can be interpreted by some investors as a positive signal (management acquiring company stock), but filings are factual records and do not state motivation.